NICE hits Keytruda with ‘no’ for urothelial cancer
The rejection comes after a review of new evidence collected while the blockbuster was available via the Cancer Drugs Fund.
Read More
Author: Anna Smith
COVID-19: NHS ‘ramp up’ testing labs as outbreak declared pandemic
As well as testing of people who meet the criteria for being at risk, the NHS and PHE are also carrying out surveillance testing on people in wards and surgeries showing signs of the virus.
Read More
Empliciti, Revlimid combo falls short in multiple myeloma
BMS is “disappointed” at the outcome.
Read More
DE-122 flops in wet AMD trial
In a trial, the addition of DE-122 to Roche’s Lucentis (ranibizumab) did not improve visual acuity compared to treatment with Lucentis alone.
Read More
NICE, Health Technology Wales announce new partnership
The two organisations have detailed plans to work together on planning and information sharing over the assessment of medical technologies.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
